Adicet Bio, Inc.
ACET· Nasdaq
Released Aug 10, 2022, before the open
10-Q filed Aug 10, 2022, 41 days after period end · 0000950170-22-016254
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$22.54M | -$10.85M | -$8.46M | -$2.65M |
| EPS Diluted | -$0.56 | -$0.34 | -$3.88 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR